[go: up one dir, main page]

Follow
Vidar Sørum
Vidar Sørum
Researcher, Evolutionary Microbiology, University of Tromsø
Verified email at uit.no
Title
Cited by
Cited by
Year
Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli
NL Podnecky, EGA Fredheim, J Kloos, V Sørum, R Primicerio, AP Roberts, ...
Nature Communications 9 (1), 3673, 2018
1162018
Fitness costs of various mobile genetic elements in Enterococcus faecium and Enterococcus faecalis
I Starikova, M Al-Haroni, G Werner, AP Roberts, V Sørum, KM Nielsen, ...
Journal of Antimicrobial Chemotherapy 68 (12), 2755-2765, 2013
1112013
Genetic dominance governs the evolution and spread of mobile genetic elements in bacteria
J Rodríguez-Beltrán, V Sørum, M Toll-Riera, C de la Vega, R Peña-Miller, ...
Proceedings of the National Academy of Sciences 117 (27), 15755-15762, 2020
942020
OXA-48-mediated ceftazidime-avibactam resistance is associated with evolutionary trade-offs
C Fröhlich, V Sørum, AM Thomassen, PJ Johnsen, HKS Leiros, ...
Msphere 4 (2), 10.1128/msphere. 00024-19, 2019
722019
Evolution of β-lactamase-mediated cefiderocol resistance
C Fröhlich, V Sørum, N Tokuriki, PJ Johnsen, Ø Samuelsen
Journal of Antimicrobial Chemotherapy 77 (9), 2429-2436, 2022
592022
Low biological cost of carbapenemase-encoding plasmids following transfer from Klebsiella pneumoniae to Escherichia coli
MC Di Luca, V Sørum, I Starikova, J Kloos, N Hülter, U Naseer, ...
Journal of Antimicrobial Chemotherapy 72 (1), 85-89, 2016
522016
Growth phase-specific evolutionary benefits of natural transformation in Acinetobacter baylyi
ALG Utnes, V Sørum, N Hülter, R Primicerio, J Hegstad, J Kloos, ...
The ISME journal 9 (10), 2221-2231, 2015
402015
Costs and benefits of natural transformation in Acinetobacter baylyi
N Hülter, V Sørum, K Borch-Pedersen, MM Liljegren, ALG Utnes, ...
BMC microbiology 17 (1), 34, 2017
342017
Spawning behaviour of Arctic charr (Salvelinus alpinus): risk of sperm competition and timing of milt release for sneaker and dominant males
V Sørum, L Figenschou, G Rudolfsen, I Folstad
Behaviour 148 (9-10), 1157-1172, 2011
262011
OXA-48-mediated ceftazidime-avibactam resistance is associated with evolutionary trade-offs. mSphere 4: e00024-19
C Fröhlich, V Sørum, AM Thomassen, PJ Johnsen, HKS Leiros, ...
182019
Evolutionary instability of collateral susceptibility networks in ciprofloxacin-resistant clinical Escherichia coli strains
V Sørum, EL Øynes, AS Møller, K Harms, Ø Samuelsen, NL Podnecky, ...
MBio 13 (4), e00441-22, 2022
122022
Structural and biochemical characterization of the environmental MBLs MYO-1, ECV-1 and SHD-1
C Fröhlich, V Sørum, S Huber, Ø Samuelsen, F Berglund, E Kristiansson, ...
Journal of Antimicrobial Chemotherapy 75 (9), 2554-2563, 2020
122020
Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli. Nat Commun 9: 3673
NL Podnecky, EGA Fredheim, J Kloos, V Sørum, R Primicerio, AP Roberts, ...
122018
OXA-48-mediated ceftazidime-avibactam resistance is associated with evolutionary trade-offs. mSphere 2019; 4 (2): e00024-19
C Fröhlich, V Sørum, AM Thomassen, PJ Johnsen, HKS Leiros, ...
Cited Here, 0
10
Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli. Nat Commun. 2018; 9: 3673
NL Podnecky, EGA Fredheim, J Kloos, V Sørum, R Primicerio, AP Roberts, ...
7
Conserved collateral susceptibility networks in diverse clinical strains of Escherichia coli
NL Podnecky, EGA Fredheim, J Kloos, V Sørum, R Primicerio, AP Roberts, ...
bioRxiv, 248872, 2018
12018
The system can't perform the operation now. Try again later.
Articles 1–16